SCHEMBL5162267

SCHEMBL5162267

CCN(CC)C(=O)Cc1cc(O)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.42
TSPO P30536 1/20 0.38
HSP90AB1 P08238 2/20 0.37
HSP90AA1 P07900 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164349 0.88 POLB (0.45) TSPOTDP1MEN1KMT2A
SCHEMBL5162643 0.85 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19TDP1
SCHEMBL5162216 0.83 SLC6A2 (0.40) HSP90AA1SLC6A2SLC6A4SLC6A3CA12
SCHEMBL11864159 0.83 HSP90AA1 (0.50) HSD17B10HSP90AB1HSP90AA1CYP1A2CYP3A4
SCHEMBL5164671 0.83 POLB (0.35) SLC6A2SLC6A4SLC6A3CA12CA1
SCHEMBL5162240 0.82 TYR (0.36) KDM4ESLC6A2SLC6A4SLC6A3CA2
SCHEMBL5159578 0.80 HDAC1 (0.34) HSD17B10CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL29379067 0.78 HSD17B10 (0.57) HSD17B10TSPOCYP1A2CYP3A4CYP2D6
SCHEMBL5270844 0.78 CYP3A4 (0.39) HSD17B10HSP90AB1CYP3A4KDM4ESLC6A2
SCHEMBL561622 0.77 MAPT (0.47) HSP90AB1CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP claimed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP disclosed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds KRT18, S100A4, CKAP4 HSD17B10 1395/4885TSPO 3563/4885HSP90AB1 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.